Clinical Trials Directory

Trials / Completed

CompletedNCT00913406

Effect of Lutein in S-26 Gold On Growth And Safety

Effect of Lutein in S-26 Gold on Growth and Safety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
232 (actual)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
14 Days
Healthy volunteers
Accepted

Summary

Study to determine if the addition of lutein to infant formula supports healthy growth and development in healthy full term infants.

Conditions

Interventions

TypeNameDescription
OTHERLutein fortification
OTHERStandard formula

Timeline

Start date
2005-11-01
Primary completion
2006-05-01
Completion
2006-05-01
First posted
2009-06-04
Last updated
2009-06-04

Source: ClinicalTrials.gov record NCT00913406. Inclusion in this directory is not an endorsement.